The Fund's primary objective is to generate income equivalent to two times (200%) that derived from selling options linked to Hims & Hers Health, Inc. (NASDAQ: HIMS) (the "Underlying Stock"). This is achieved by writing options on a leveraged exchange-traded fund (the "Underlying Leveraged ETF") that itself targets twice (200%) the daily performance of the Underlying Stock. A secondary goal is to provide investors with exposure to the performance of this Underlying Leveraged ETF, albeit with a ceiling on potential investment returns. Furthermore, the Fund may implement measures for downside protection, a factor that could influence its ultimate net income.
Per-holder 13F data isn't yet ingested for ETFs — coming with the next data layer expansion.